These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 32316005)
1. Are Immunohistochemical Markers Useful in Phenotypic Gastric Cancer Classification? Di Pinto F; Armentano R; Arborea G; Schena N; Donghia R; Valentini AM Oncology; 2020; 98(8):566-574. PubMed ID: 32316005 [TBL] [Abstract][Full Text] [Related]
2. Prevalence of Epstein-Barr Virus Infection and Mismatch Repair Protein Deficiency and the Correlation of Immune Markers in Tibetan Patients with Gastric Cancer. Shi J; Yang X; Wang X; Luo Y; Zhou W; Luo H; Bianba Z; Nima Z; Wang Q; Wang H; Liao R; Ciren Q; Li M; Pang J Biomed Res Int; 2022; 2022():2684065. PubMed ID: 35734348 [TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and prognostic features of Epstein-Barr virus infection, microsatellite instability, and PD-L1 expression in gastric cancer. Pereira MA; Ramos MFKP; Faraj SF; Dias AR; Yagi OK; Zilberstein B; Cecconello I; Alves VAF; de Mello ES; Ribeiro U J Surg Oncol; 2018 Apr; 117(5):829-839. PubMed ID: 29534305 [TBL] [Abstract][Full Text] [Related]
4. Comprehensive expression profiles of gastric cancer molecular subtypes by immunohistochemistry: implications for individualized therapy. Kim HS; Shin SJ; Beom SH; Jung M; Choi YY; Son T; Kim HI; Cheong JH; Hyung WJ; Noh SH; Chung H; Park JC; Shin SK; Lee SK; Lee YC; Koom WS; Lim JS; Chung HC; Rha SY; Kim H Oncotarget; 2016 Jul; 7(28):44608-44620. PubMed ID: 27331626 [TBL] [Abstract][Full Text] [Related]
5. Clinicopathological features of 22C3 PD-L1 expression with mismatch repair, Epstein-Barr virus status, and cancer genome alterations in metastatic gastric cancer. Kawazoe A; Shitara K; Kuboki Y; Bando H; Kojima T; Yoshino T; Ohtsu A; Ochiai A; Togashi Y; Nishikawa H; Doi T; Kuwata T Gastric Cancer; 2019 Jan; 22(1):69-76. PubMed ID: 29859006 [TBL] [Abstract][Full Text] [Related]
6. Programmed death-ligand 1 expression in gastric cancer: correlation with mismatch repair deficiency and HER2-negative status. Wang L; Zhang Q; Ni S; Tan C; Cai X; Huang D; Sheng W Cancer Med; 2018 Jun; 7(6):2612-2620. PubMed ID: 29673110 [TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus positivity, not mismatch repair-deficiency, is a favorable risk factor for lymph node metastasis in submucosa-invasive early gastric cancer. Park JH; Kim EK; Kim YH; Kim JH; Bae YS; Lee YC; Cheong JH; Noh SH; Kim H Gastric Cancer; 2016 Oct; 19(4):1041-1051. PubMed ID: 26573601 [TBL] [Abstract][Full Text] [Related]
8. Reproduction of the Cancer Genome Atlas (TCGA) and Asian Cancer Research Group (ACRG) Gastric Cancer Molecular Classifications and Their Association with Clinicopathological Characteristics and Overall Survival in Moroccan Patients. Nshizirungu JP; Bennis S; Mellouki I; Sekal M; Benajah DA; Lahmidani N; El Bouhaddouti H; Ibn Majdoub K; Ibrahimi SA; Celeiro SP; Viana-Pereira M; Munari FF; Ribeiro GG; Duval V; Santana I; Reis RM Dis Markers; 2021; 2021():9980410. PubMed ID: 34367379 [TBL] [Abstract][Full Text] [Related]
9. Receptor tyrosine kinase amplified gastric cancer: Clinicopathologic characteristics and proposed screening algorithm. Park CK; Park JS; Kim HS; Rha SY; Hyung WJ; Cheong JH; Noh SH; Lee SK; Lee YC; Huh YM; Kim H Oncotarget; 2016 Nov; 7(44):72099-72112. PubMed ID: 27765925 [TBL] [Abstract][Full Text] [Related]
10. Predictive value of MLH1 and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer. Hashimoto T; Kurokawa Y; Takahashi T; Miyazaki Y; Tanaka K; Makino T; Yamasaki M; Nakajima K; Ikeda JI; Mori M; Doki Y Gastric Cancer; 2019 Jul; 22(4):785-792. PubMed ID: 30617648 [TBL] [Abstract][Full Text] [Related]
11. Biomarkers of EBV-positive Gastric Cancers: Loss of PTEN Expression is Associated with Poor Prognosis and Nodal Metastasis. Kang HJ; Lee IS; Park YS; Ho WJ; Sohn D; Ahn JY; Yook JH; Kim BS Ann Surg Oncol; 2016 Oct; 23(11):3684-3692. PubMed ID: 27221363 [TBL] [Abstract][Full Text] [Related]
12. Expression Profile of Markers for Targeted Therapy in Gastric Cancer Patients: HER-2, Microsatellite Instability and PD-L1. Pereira MA; Ramos MFKP; Dias AR; Faraj SF; Ribeiro RRE; de Castria TB; Zilberstein B; Alves VAF; Ribeiro U; de Mello ES Mol Diagn Ther; 2019 Dec; 23(6):761-771. PubMed ID: 31595457 [TBL] [Abstract][Full Text] [Related]
13. PD-L1 expression is associated with massive lymphocyte infiltration and histology in gastric cancer. Li Z; Lai Y; Sun L; Zhang X; Liu R; Feng G; Zhou L; Jia L; Huang X; Kang Q; Lin D; Gao J; Shen L Hum Pathol; 2016 Sep; 55():182-9. PubMed ID: 27260946 [TBL] [Abstract][Full Text] [Related]
14. Gastric Carcinomas With Lymphoid Stroma: An Evaluation of the Histopathologic and Molecular Features. Hissong E; Ramrattan G; Zhang P; Zhou XK; Young G; Klimstra DS; Shia J; Fernandes H; Yantiss RK Am J Surg Pathol; 2018 Apr; 42(4):453-462. PubMed ID: 29438172 [TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic Features and Prognostic Significance of Immunohistochemistry and In Situ Hybridization Based Molecular Classification in Gastric Carcinoma. Issin G; Sayar İ; Demir F; Bakkaloğlu İG; Gamsizkan M; Yildiz Z; Yilmaz I; Özmen SA; Çağatay DV; Zemheri IE; Demiriz M; Günal A J Environ Pathol Toxicol Oncol; 2023; 42(4):1-14. PubMed ID: 37522564 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemistry as a surrogate for molecular subtyping of gastric adenocarcinoma. Gonzalez RS; Messing S; Tu X; McMahon LA; Whitney-Miller CL Hum Pathol; 2016 Oct; 56():16-21. PubMed ID: 27342907 [TBL] [Abstract][Full Text] [Related]
17. Clinicopathological features of tumor mutation burden, Epstein-Barr virus infection, microsatellite instability and PD-L1 status in Chinese patients with gastric cancer. Zhang L; Wang Y; Li Z; Lin D; Liu Y; Zhou L; Wang D; Wu A; Li Z Diagn Pathol; 2021 May; 16(1):38. PubMed ID: 33933102 [TBL] [Abstract][Full Text] [Related]
18. Functional loss of ARID1A is tightly associated with high PD-L1 expression in gastric cancer. Kim YB; Ahn JM; Bae WJ; Sung CO; Lee D Int J Cancer; 2019 Aug; 145(4):916-926. PubMed ID: 30664822 [TBL] [Abstract][Full Text] [Related]
19. High PD-L1 expression in gastric cancer (GC) patients and correlation with molecular features. Liu X; Choi MG; Kim K; Kim KM; Kim ST; Park SH; Cristescu R; Peter S; Lee J Pathol Res Pract; 2020 Apr; 216(4):152881. PubMed ID: 32089413 [TBL] [Abstract][Full Text] [Related]
20. PD-L1 and CD8 are associated with deficient mismatch repair status in triple-negative and HER2-positive breast cancers. Hou Y; Nitta H; Parwani AV; Li Z Hum Pathol; 2019 Apr; 86():108-114. PubMed ID: 30633926 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]